Temporary management of upper lid ptosis, lid malposition, and eyelid fissure asymmetry with botulinum toxin type A

Plastic and Reconstructive Surgery

Volumn 114, Issue 7, 2004, Pages 1892-1902

  Fagien, Steven ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BOTULINUM TOXIN A; NAPHAZOLINE; VASOCON A;

ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG USE; EPIPHORA; ESTHETICS; EYELID DISEASE; EYELID FISSURE ASYMMETRY; EYELID MALPOSITION; FACE ASYMMETRY; FACE MUSCLE; HUMAN; KERATITIS; LAGOPHTHALMOS; PALPEBRAL FISSURE; PATIENT REFERRAL; PATIENT SELECTION; PRIORITY JOURNAL; PTOSIS; TREATMENT OUTCOME; VISUAL DISORDER;

ADULT; BELL PALSY; BLEPHAROPTOSIS; BOTULINUM TOXIN TYPE A; HUMANS; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; RECONSTRUCTIVE SURGICAL PROCEDURES; RECURRENCE;

EID: 14944383694     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000142744.55379.8D     Document Type: Article

References (11)

1. Anderson, R. L., and Gordy, D. D. The tarsal strip procedure. Arch. Ophthalmol. 97: 2192, 1979.
2. Anderson, R. L., and Dixon, R. S. Aponeurotic ptosis surgery. Arch. Ophthalmol. 97: 1123, 1979.
3. Putterman, A. M., and Urist, M. J. Muller muscle-conjunctival resection. Arch. Ophthalmol. 93: 619, 1975.
4. Fagien, S., and Brandt, F. S. Primary and adjunctive use of Botox in facial aesthetic surgery: Beyond the glabella. In A. Matarasso and S. L. Matarasso (Eds.), Clinics in Plastic Surgery. Philadelphia: Saunders, 2000. Pp. 127-148.
5. Fagien, S. Extended use of botulinum toxin A in facial aesthetic surgery. Aesthetic Surg. J. 18: 215, 1998.
6. Fagien, S. Botox for the treatment of dynamic and hyper-kinetic facial lines and furrows: Adjunctive use in facial aesthetic surgery. Plast. Reconstr. Surg. 103: 701, 1999.
7. Scott, A. B., Kennedy, R. A., and Stubbs, H. A. Botulinum toxin injection as a treatment for blepharospasm. Arch. Ophthalmol. 103: 347, 1985.
8. Uddin, J. M., and Davies, P. D. Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection. Ophthalmology 109: 1183, 2002.
9. Fagien, S. Aesthetic periorbital application of Botox: Cause and effect. Presented at the Botox National Training Center Faculty Meeting, Denver, Colo., June 2003.
10. Fagien, S. Botulinum toxin type A for facial aesthetic enhancement: Role in facial shaping. Plast. Reconstr. Surg. 112 (Suppl.): 6S, 2003.
11. Fagien, S. Botulinum toxin type A for the treatment of mild upper eyelid ptosis. Teaching Course: Botulinum toxin type A for the Aesthetic Plastic Surgeon. Presented at the Annual Meeting of the American Society of Aesthetic Plastic Surgeons, New York, N.Y., May 5, 2001.